Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
380.50    -26.50 (-6.51%)
Bid:
381.00
Ask:
382.50
Spread: 1.50 (0.394%)
Market Cap: £1.72b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Final Results

16 Mar 2012 07:00

RNS Number : 4686Z
HgCapital Trust plc
16 March 2012
 



HgCapital Trust plc

Final results for the year ended 31 December 2011

 

London, 16 March 2012: HgCapital Trust plc ("Trust"), which provides investors with a listed vehicle to invest in all private equity deals managed by HgCapital, today announces its full year results for the year ended 31 December 2011.

 

HGCAPITAL TRUST PLC CONTINUES TO DELIVER LONG TERM OUTPERFORMANCE

 

Summary performance

31 December2011

 31 December2010

%Change

% Totalreturn*

Share price

970.0p

1,006.0p

-3.6%

-1.2%

NAV per share

(diluted)

1,069.3p

1,090.7p

-2.0%

+0.5%

(basic)

1,089.9p

1,118.8p

-2.6%

-0.2%

FTSE All-Share Index

-3.5%

 

 

Movement

 

Net Asset Value

£346.8m

£348.0m

-£1.2m

* Assuming reinvestment of all dividends

 

Financial Highlights

§ Sales and EBITDA growth from top 20 buyout investments of +13% and +10% respectively over last 12 months to 31 December 2011.

§ Valuation multiple of 10.2x EBITDA (Dec 10: 9.7x) and debt multiple of 4.0x EBITDA (Dec 10: 3.6x) as at 31 December 2011.

§ Total available liquid resources were £94m (27% of NAV) with outstanding commitments of £195m (56% of NAV).

§ +15.7% p.a. 10-year compound annual growth rate of the share price on a total return basis vs. 4.8% p.a. from the FTSE All-Share Index on a total return basis to 31 December 2011.

 

Operational Highlights

§ £87m deployed over the period, principally in five new buyout investments.

§ £62m of cash proceeds from 2011 realisations; full exits achieved in aggregate at a 56% uplift to 31 December 2010 book value.

§ The Trust was chosen, for the seventh consecutive year, as Private Equity Investment Trust of the Year in the 'Investment Week' awards.

 

Events since 31 December 2011

§ Proposed final dividend for the year of 10.0 pence per ordinary share to be paid on 10 May 2012, subject to shareholder approval.

§ NAV per share at 29 February 2012 was 1,080.2p (diluted) and 1,102.7p (basic); movement from December mainly due to foreign exchange fluctuations.

 

Outlook

§ 80% of the balance sheet invested in buyouts of which c. 80% is in companies with a low exposure to the weak macro-economic cycle and only 20% is in companies where ratings and earnings are sensitive to the economy.

§ Market leading businesses, with low gearing in growth segments, well placed for platform builds.

§ Interest in a number of our businesses may result in successful realisations over the next 12 months.

§ New investment will continue to be highly selective by only investing in businesses that meet our thematic criteria and can be bought for value.

§ Owning a portfolio of quality companies run by talented managers should build significant shareholder value over the medium-term.

 

 

Long Term Total Return Performance*

1 year%

3 years % p.a.

5 years% p.a.

7 years% p.a.

10 years% p.a.

Ordinary share price

(1.2)

16.4

8.6

14.2

15.7

Net asset value (diluted)

0.5

7.6

10.2

14.4

13.2

FTSE All-Share Index

(3.5)

12.9

1.2

6.1

4.8

Share price outperformance p.a. against the FTSE All Share Index

2.3

3.5

7.4

8.1

10.9

* Assuming reinvestment of all dividends

 

 

Roger Mountford, Chairman of the Trust, commented:

 

"The Trust has protected shareholder value during a poor year in equity markets. The portfolio is trading well the top 20 buyouts having delivered double digit revenue and profit growth over the year. The Trust continues to deliver long-term outperformance and offers the prospect of renewed growth in value for shareholders."

 

- Ends -

 

The Trust 2011 Annual Report and a webcast from the Manager to accompany the results are available to view at: http://www.hgcapitaltrust.com/.

 

For further details:

 

HgCapital

Ian Armitage (Chairman, HgCapital)

Roger Mountford (Chairman, HgCapital Trust plc)

+44 (0)20 7089 7888

+44 (0) 7799 662601

 

Maitland

+44 (0)20 7379 5151

Rowan Brown

George Hudson

 

About HgCapital Trust plc

 

HgCapital Trust plc is an investment trust whose shares are listed on the London Stock Exchange. The Trust gives investors exposure, through a liquid vehicle, to a portfolio of high-growth private companies, managed by HgCapital, an experienced and well-resourced private equity firm with a long-term track record of delivering superior risk-adjusted returns for its investors.

 

For further details, see www.hgcapitaltrust.com and www.hgcapital.com

 

Neither the contents of HgCapital's website, HgCapital Trust's website nor the contents of any website accessible from hyperlinks on the websites (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SFAFAIFESEDD
Date   Source Headline
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution
29th Apr 20221:38 pmRNSDirectorate Change
11th Apr 20223:00 pmRNSHg announces investment in LucaNet
1st Apr 20229:45 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.